Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

SQZ

SQZ Biotechnologies (SQZ)

SQZ Biotechnologies Company
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:SQZ
일자시간출처헤드라인심볼기업
2022/06/2119:45Business WireSQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual MeetingNYSE:SQZSQZ Biotechnologies Company
2022/06/1706:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
2022/06/1706:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
2022/06/1706:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
2022/06/1706:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
2022/06/1706:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
2022/06/1702:05TipRanksBrookline Capital Markets Thinks SQZ Biotechnologies’ Stock is Going to RecoverNYSE:SQZSQZ Biotechnologies Company
2022/06/1619:45Business WireSQZ Biotechnologies Announces Generation of Dopaminergic Neurons from Human Pluripotent Stem Cells Through Single-Step Delivery of Six Cell-Fate Encoding RNAsNYSE:SQZSQZ Biotechnologies Company
2022/06/0405:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
2022/06/0405:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:SQZSQZ Biotechnologies Company
2022/06/0205:45Business WireSQZ Biotechnologies to Present at Jefferies Healthcare ConferenceNYSE:SQZSQZ Biotechnologies Company
2022/06/0105:53Edgar (US Regulatory)Current Report Filing (8-k)NYSE:SQZSQZ Biotechnologies Company
2022/06/0105:45Business WireSQZ Biotechnologies Appoints Marshelle Smith Warren, M.D., as Chief Medical OfficerNYSE:SQZSQZ Biotechnologies Company
2022/05/2806:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
2022/05/2005:08Edgar (US Regulatory)Current Report Filing (8-k)NYSE:SQZSQZ Biotechnologies Company
2022/05/1908:35TipRanksBrookline Capital Markets Keeps a Buy Rating on SQZ Biotechnologies (SQZ)NYSE:SQZSQZ Biotechnologies Company
2022/05/1819:45Business WireSQZ Biotechnologies Announces Integrated Point-of-Care Cell Therapy Manufacturing System Demonstrated Comparable or Better Performance Than a More Conventional Clean Room-Based ProcessNYSE:SQZSQZ Biotechnologies Company
2022/05/1409:45TipRanksBrookline Capital Markets Thinks SQZ Biotechnologies’ Stock is Going to RecoverNYSE:SQZSQZ Biotechnologies Company
2022/05/1105:50Business WireSQZ Biotechnologies Reports First Quarter 2022 Financial Results and Recent Portfolio UpdatesNYSE:SQZSQZ Biotechnologies Company
2022/05/1105:37Edgar (US Regulatory)Quarterly Report (10-q)NYSE:SQZSQZ Biotechnologies Company
2022/05/0605:45Business WireSQZ Biotechnologies to Host Live & Virtual R&D Investor Event on May 19, 2022NYSE:SQZSQZ Biotechnologies Company
2022/05/0519:45Business WireSQZ Biotechnologies Announces First Data Presentation on Non-Clinical Studies of Point-of-Care Manufacturing System and Collaboration with STEMCELL Technologies on Research-Use-Only System to Fuel Preclinical ResearchNYSE:SQZSQZ Biotechnologies Company
2022/05/0405:30Business WireSQZ Biotechnologies to Present at Upcoming Investor ConferencesNYSE:SQZSQZ Biotechnologies Company
2022/04/2901:10Dow Jones NewsSQZ Shares Rise After Tumor Treatment Gets Fast-Track DesignationNYSE:SQZSQZ Biotechnologies Company
2022/04/2807:56TipRanksSQZ Biotechnologies (SQZ) Gets a Buy Rating from Brookline Capital MarketsNYSE:SQZSQZ Biotechnologies Company
2022/04/2805:45Business WireSQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ TumorsNYSE:SQZSQZ Biotechnologies Company
2022/04/2706:08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:SQZSQZ Biotechnologies Company
2022/04/2706:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:SQZSQZ Biotechnologies Company
2022/04/1302:35TipRanksBrookline Capital Markets Thinks SQZ Biotechnologies’ Stock is Going to RecoverNYSE:SQZSQZ Biotechnologies Company
2022/04/1119:45Business WireSQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In VivoNYSE:SQZSQZ Biotechnologies Company
 검색 관련기사 보기:NYSE:SQZ

최근 히스토리

Delayed Upgrade Clock